CAS 100021-05-4

Levonorgestrel EP Impurity P

CAS: 100021-05-4

Formel: C₂₁H₂₈O₂

Molekulargewicht: 312.45

Ref: ST-EA-CP-L19016

Levonorgestrel EP Impurity P

CAS: 100021-05-4

Formel: C₂₁H₂₈O₂

Farbe und Form: White To Off-White Solid

Molekulargewicht: 312.45

Ref: 4Z-L-2210

5(6)-Dehydro-4(5)-dihydro D-(-)-Norgestrel (>90%)

Kontrolliertes Produkt

CAS: 100021-05-4

Impurity Levonorgestrel EP Impurity P
Applications 5(6)-Dehydro-4(5)-dihydro D-(-)-Norgestrel (Levonorgestrel EP Impurity P) is a Norgestrel (N689500) impurity.

Formel: C₂₁H₂₈O₂

Reinheit: >90%

Farbe und Form: Neat

Molekulargewicht: 312.45

Ref: TR-D229935

Levonorgestrel EP Impurity P

CAS: 100021-05-4

Soluble in Chloroform & in Methanol Confirmed
Insoluble in Wate

Reinheit: 90% min

Farbe und Form: Off White or Beige Solid

Molekulargewicht: 312.45

Ref: ML-LNG16

Vitamin A EP Impurity C

CAS: 100021-05-4

Soluble in Chloroform & in Methanol Confirmed
Insoluble in Wate

Reinheit: 90% min

Farbe und Form: Off White or Beige Solid

Molekulargewicht: 312.45

Ref: ML-VTA03

(17a)-13-Ethyl-17-hydroxy-18,19-dinorpregn-5-en-20-yn-3-one

Kontrolliertes Produkt

CAS: 100021-05-4

(17a)-13-Ethyl-17-hydroxy-18,19-dinorpregn-5-en-20-yn-3-one is a progestin that acts as an inhibitor of the P450 enzyme. It has been used in the treatment of women with fertility problems. (17a)-13-Ethyl-17-hydroxy-18,19-dinorpregn-5-en--20--yn--3--one has shown inhibitory effects on voltage dependent calcium channels and thus may have contraceptive properties. It has also been shown to be effective in the long term treatment of intrauterine devices. Low bioavailability is a disadvantage of this drug.br>br>

Formel: C₂₁H₂₈O₂

Reinheit: Min. 95%

Farbe und Form: Powder

Molekulargewicht: 312.45 g/mol

Ref: 3D-FE20961